# Cardiac Left Atrial Evaluation and Response in HFrEF With Sacubitril/Valsartan

> **NCT07088471** · — · COMPLETED · sponsor: **Connolly Hospital Blanchardstown** · enrollment: 334 (actual)

## Conditions studied

- Heart Failure and Reduced Ejection Fraction

## Interventions

- **DRUG:** Sacubtril/Valsartan

## Key facts

- **NCT ID:** NCT07088471
- **Lead sponsor:** Connolly Hospital Blanchardstown
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 334 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07088471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07088471, "Cardiac Left Atrial Evaluation and Response in HFrEF With Sacubitril/Valsartan". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07088471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*